NGM Biopharmaceuticals, Inc. (NGM) Earnings
|
Expand Research on NGM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +14.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/2/24 | Q124 | N/A | -$0.35 | N/A | N/A | $218.65K | N/A | N/A | N/A | ||
| 3/11/24 | Q423 | -$0.33 | -$0.39 | +$0.06 | N/A | $558.2K | N/A |  | | Details | |
| 2/27/24 | Q423 | N/A | -$0.39 | N/A | N/A | $558.2K | N/A | N/A | N/A | ||
11/3/23  |
Q323 | -$0.35 | -$0.42 | +$0.07 | $580K | $2.46M | N/A | | | Details | |
| 11/2/23 |
Q323 | -$0.35 | -$0.42 | +$0.07 | $580K | $2.46M | N/A | | | Details | |
| 8/15/23 | Q223 | N/A | -$0.50 | N/A | N/A | $3.3M | N/A | N/A | N/A | ||
| 8/3/23 |
Q223 | -$0.46 | -$0.50 | +$0.04 | $1.42M | $3.3M | N/A | | | Details | |
| 5/18/23 | Q123 | N/A | -$0.52 | N/A | N/A | $6.72M | N/A | N/A | N/A |
